Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma

58Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Five patients receiving increased dose or frequency of pamidronate beyond the recommended dose (90 mg/monthly) exhibited nephrotic proteinuria (range 3.96-24 g/24 h). On dose reduction or discontinuation, three of these patients showed decreased proteinuria to normal levels (< 1 g/24 h), and proteinuria decreased to 4.5 g/24 h from a peak of 24 g/24 h in one patient. One patient on haemodialysis (hence not evaluable) had proteinuria of 2 g/24 h and elevated creatinine levels. One other patient continued to show elevated creatinine levels (272.8 μmol/l). Renal biopsies obtained in two patients revealed focal segmental glomerulosclerosis.

Author supplied keywords

Cite

CITATION STYLE

APA

Desikan, R., Veksler, Y., Raza, S., Stokes, B., Sabir, T., Li, Z. J., & Jagannath, S. (2002). Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. British Journal of Haematology, 119(2), 496–499. https://doi.org/10.1046/j.1365-2141.2002.03826.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free